Tower Research Capital LLC (Trc) Vaccinex, Inc. Transaction History

Tower Research Capital LLC (Trc)

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.34 - $0.48 $2,427 - $3,427	7,141 Added 29.42%	31,415 $11,000
Q1 2023 May 09, 2023	BUY	$0.39 - $0.65 $9,466 - $15,778	24,274 New	24,274 $10,000
Q1 2022 May 12, 2022	SELL	$0.92 - $1.94 $3,011 - $6,349	-3,273 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.04 - $2.12 $778 - $1,587	749 Added 29.68%	3,273 $3,000
Q3 2021 Nov 15, 2021	BUY	$2.11 - $2.81 $5,325 - $7,092	2,524 New	2,524 $5,000
Q2 2021 Aug 16, 2021	SELL	$2.01 - $3.0 $108,097 - $161,340	-53,780 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.09 - $5.11 $99,118 - $242,341	47,425 Added 746.26%	53,780 $161,000
Q4 2020 Feb 16, 2021	BUY	$1.66 - $2.35 $10,549 - $14,934	6,355 New	6,355 $13,000
Q3 2020 Nov 16, 2020	SELL	$1.75 - $8.19 $794 - $3,718	-454 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$3.28 - $4.24 $1,489 - $1,924	454 New	454 $2,000
Q2 2019 Aug 13, 2019	SELL	$4.89 - $8.11 $264 - $437	-54 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$3.67 - $5.5 $198 - $297	54 New	54 $0
Q4 2018 Feb 14, 2019	SELL	$3.64 - $7.12 $6,435 - $12,588	-1,768 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$6.95 - $11.64 $12,287 - $20,579	1,768 New	1,768 $13,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $240M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.